These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 31651841
1. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study. Wu B, Hu X, Jin H, Zhou L, Zhang D, Man Z, Wang Y, Yang S, Pang Q, Liu H, Cui P. Medicine (Baltimore); 2019 Oct; 98(43):e17394. PubMed ID: 31651841 [Abstract] [Full Text] [Related]
4. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy. Wang ZX, Peng W, Zhang XY, Wen TF, Li C. Medicine (Baltimore); 2021 Mar 19; 100(11):e24476. PubMed ID: 33725934 [Abstract] [Full Text] [Related]
7. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection. Li C, Zhang XY, Peng W, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ, Chen LP. Medicine (Baltimore); 2018 Jul 19; 97(29):e11599. PubMed ID: 30024565 [Abstract] [Full Text] [Related]
12. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era. Liu PH, Hsu CY, Hsia CY, Lee YH, Chiou YY, Huang YH, Lee FY, Lin HC, Hou MC, Huo TI. J Gastroenterol Hepatol; 2017 Apr 19; 32(4):879-886. PubMed ID: 27696519 [Abstract] [Full Text] [Related]
13. The Significance of Platelet-Albumin-Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count. Pang Q, Liu S, Wang L, Pan H, Wang C, Zhou L, Lu Y, Liu H. Cancer Manag Res; 2020 Apr 19; 12():12811-12822. PubMed ID: 33364830 [Abstract] [Full Text] [Related]
14. Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia. Man ZR, Gong XK, Qu KL, Pang Q, Wu BQ. World J Gastrointest Oncol; 2024 May 15; 16(5):1763-1772. PubMed ID: 38764822 [Abstract] [Full Text] [Related]
15. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H. J Gastroenterol Hepatol; 2016 May 15; 31(5):1031-6. PubMed ID: 26647219 [Abstract] [Full Text] [Related]
16. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria. Li C, Zhang XY, Peng W, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ. World J Surg; 2018 Jun 15; 42(6):1841-1847. PubMed ID: 29138913 [Abstract] [Full Text] [Related]
17. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis. Oikonomou T, Goulis L, Doumtsis P, Tzoumari T, Akriviadis E, Cholongitas E. Ann Hepatol; 2019 Jun 15; 18(1):126-136. PubMed ID: 31113581 [Abstract] [Full Text] [Related]
18. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment. Hu K, Yuan J, Tang B, Zhang F, Lu S, Chen R, Zhang L, Ren Z, Yin X. Ann Transl Med; 2021 Feb 15; 9(3):237. PubMed ID: 33708864 [Abstract] [Full Text] [Related]
19. Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection. Amisaki M, Uchinaka E, Morimoto M, Tokuyasu N, Sakamoto T, Honjo S, Saito H, Fujiwara Y. Hepatobiliary Pancreat Dis Int; 2018 Dec 15; 17(6):502-509. PubMed ID: 30077606 [Abstract] [Full Text] [Related]
20. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Casadei Gardini A, Foschi FG, Conti F, Petracci E, Vukotic R, Marisi G, Buonfiglioli F, Vitale G, Ravaioli F, Gitto S, Verucchi G, Lenzi M, Bolondi L, Mazzella G, Brillanti S, Andreone P, member of the Bologna DAA group. Dig Liver Dis; 2019 May 15; 51(5):681-688. PubMed ID: 30327251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]